Zhengye Biotechnology Holding Ltd (ZYBT) stock
ZYBTNasdaqPharmaceutical Preparations
$1.48−0.04 (-2.63%)
Close on Nov 20, 2026Market cap $70.14MP/E –Yield –
Zhengye Biotechnology free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was CN¥12.33M, down 55.1% from the year before.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CN¥12.33M | -55.1% |
| FY2024 | Dec 31, 2024 | CN¥27.46M | -32.7% |
| FY2023 | Dec 31, 2023 | CN¥40.79M | – |
| FY2022 | Dec 31, 2022 | -CN¥9.99M | – |
See a number that looks wrong?